SheMed raises $50M to expand women's GLP-1 weight management platform

London-based women's healthcare technology company SheMed has secured $50 million in funding. 

WHAT IT DOES

The women's health company offers branded GLP-1 medications and a weight management platform. It first provides individuals with a GLP-1 blood test to screen for health markers and then it tailors one's treatment plan based on their health markers. 



from MobiHealthNews Feed https://ift.tt/evETjJW
via shoppergalleries

Comments

Popular posts from this blog

Soup for Supper: How to Build a Filling, Lower-Calorie Bowl

Greg Whisman, Caremore

Let a Thousand DNA Flowers Bloom